HMGA proteins: Flexibility finds a nuclear niche?

Biochemistry and Cell Biology

Volumn 81, Issue 3, 2003, Pages 185-195

  Reeves, Raymond ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Chromatin; Gene activation; High performance liquid chromatography; HMG I(Y); Mass spectrometry; Transcription

Indexed keywords

COMPLEXATION; DNA; GENETIC ENGINEERING; MOLECULAR STRUCTURE; PROTEINS;

DNA REPLICATION;

BIOCHEMISTRY;

DNA; HIGH MOBILITY GROUP A PROTEIN; MESSENGER RNA; RNA;

BIOCHEMISTRY; CELL NUCLEUS; CHROMATIN; CONFERENCE PAPER; DNA REPAIR; DNA REPLICATION; ENZYME SUBSTRATE; GENE ACTIVATION; GENETIC TRANSCRIPTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VIVO STUDY; MAMMAL; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; RNA PROCESSING;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL NUCLEUS; CHROMATIN; DNA; GENE EXPRESSION REGULATION; HIGH MOBILITY GROUP PROTEINS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NUCLEOSOMES; PLANT PROTEINS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

MAMMALIA;

EID: 0042388088     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o03-044     Document Type: Conference Paper

References (76)

1. Ashar, H.R., Fejzo, M.S., Tkachenko, A., Zhou, X., Fletcher, J.A., Weremowicz, S., Morton, C.C., and Chada, K. 1995. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell, 82: 57-65.
2. Attema, J.L., Reeves, R., Murray, V., Levichkin, I., Temple, M.D., Tremethick, D.J., and Shannon, M.F. 2002. The human IL-2 gene promoter can assemble a positioned nucleosome that becomes remodeled upon T cell activation. J. Immunol. 169: 2466-2476.
3. Bagga, R., Michalowski, S., Sabnis, R., Griffith, J.D., and Emerson, B.M. 2000. HMG I/Y regulates long-range enhancer-dependent transcription on DNA and chromatin by changes in DNA topology. Nucleic Acids Res. 28: 2541-2550.
4. Banks, G.C., Mohr, B., and Reeves, R. 1999. The HMG-I(Y) A.T-hook peptide motif confers DNA-binding specificity to a structured chimeric protein. J. Biol. Chem. 274: 16 536-16 544.
5. Banks, G.C., Li, Y., and Reeves, R. 2000. Differential in vivo modifications of the HMGI(Y) nonhistone chromatin proteins modulate nucleosome and DNA interactions. Biochemistry, 39: 8333-8346.
6. Beckerbauer, L. 2002. Role of HMGA1 proteins in transcriptional activation of the IL-2Rα gene. Ph.D. Thesis. Department of Biochemistry/Biophysics, School of Molecular Biosciences; Washington State University, Pullman, WA, 99164. pp. 1-225.
7. Beckerbauer, L., Tepe, J.J., Cullison, J., Reeves, R., and Williams, R.M. 2000. FR900482 class of anti-tumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo. Chem. Biol. 7: 805-812.
8. Beckerbauer, L., Tepe, J.J., Eastman, R.A., Mixter, P., Williams, R.M., and Reeves, R. 2002. Differential effects of FR900482 and FK317 on apoptosis, IL-2 gene expression, and induction of vascular leak syndrome. Chem. & Biol. 9: 427-441.
9. Bourachot, B., Yaniv, M., and Muchardt, C. 1999. The activity of mammalian brm/SNF2α is dependent on a high-mobility-group protein I/ Y-like DNA binding domain. Mol. Cell. Biol. 19: 3931-3939.
10. Bussemakers, M.J., van de Ven, W.J., Debruyne, F.M., and Schalken, J.A. 1991. Identification of high mobility group protien I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res. 51: 606-611.
11. Bustin, M. 2001. Revised nomenclature for High Mobility Group (HMG) chromosomal proteins. Trends Biochem. Sci. 26: 152-153.
12. Bustin, M., and Reeves, R. 1996. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog. Nucleic Acid Res. Mol. Biol. 54: 35-100.
13. Chuvpilo, S., Schomberg, C., Gerwig, R., Heinfling, A., Reeves, R., Grummt, F., and Serfling, E. 1993. Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res. 21: 5694-5704.
14. Cross, S.L., Halden, N.F., Feinberg, B., Wolf, J.B., Holbrook, N.J., Wong-Staal, F., and Leonard, W.J. 1987a. Regulation of the human interleuking-2 receptor α chain gene promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-1. Cell, 49: 47-56.
15. Cross, S.L., Halden, N.F., Lenardo, J., and Leonard, W.J. 1987b. Functionally distinct NF-kappa B binding sites in the Igk and IL-2 receptor alpha chain genes. Science (Washington, D.C.), 244: 466-469.
16. Disney, J.E., Johnson, K.R., Magnuson, N.S., Sylvester, S.R., and Reeves, R. 1989. High-mobility group protein HMG-I localizes to G/Q- and C-bands of human and mouse chromosomes. J. Cell Biol. 109: 1975-1982.
17. Dunker, A.K., Lawson, D., Brown, C.J., Romero, P., Oh, J., Oldfield, C.J., Campen, A.M., Ratliff, C.M., Hipps, K.W., Ausio, J., Nissen, M.S., Reeves, R., Kang, C.H., Kissinger, C.R., Bailey, R.W., Griswold, M.D., Chiu, W., Garner, E.C., and Obradovic, Z. 2001. Intrinsically disordered proteins. J. Mol. Graph. Model. 19: 1-65.
18. Dyson, H.J., and Wright, P.E. 2002. Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 12: 54-60.
19. Elton, T.S. 1986a. Purification and characterization of the High Mobility Group nonhistone chromatin proteins. Ph.D. Thesis. Prog. Biochemisty/Biophysics, Washington State University, Pullman, WA 99164. pp. 1-134.
20. Elton, T.S., and Reeves, R. 1985a. Microheterogeneity of the mammalian High-Mobility Group proteins 14 and 17 investigated by reverse-phase high-performance liquid chromatography. Anal. Biochem. 146: 448-460.
21. Elton, T.S., and Reeves, R. 1985b. Microheterogeneity of the mammalian High Mobility Group (HMG) proteins 1 and 2 investigated by reverse-phase high performance liquid chromatography. Anal. Biochem. 144: 403-416.
22. Elton, T.S., and Reeves, R. 1985c. The effects of oxidation on the reverse-phase high performance liquid chromatographic characteristics of HMG-1 and HMG-2 proteins. Anal. Biochem. 149: 315-321.
23. Elton, T.S., and Reeves, R. 1986. Purification and postsynthetic modifications of Friend erythroleukemic cell High Mobility Group protein HMG-I. Anal. Biochem. 157: 53-62.
24. Fashena, S.J., Reeves, R., and Ruddle, N.H. 1992. A poly-(dA-dT) upstream activating sequence binds high-mobility group I protein and contributes to lymphotoxin (tumor necrosis factor-beta) gene regulation. Mol. Cell. Biol. 12: 894-903.
25. Fedele, M., Battista, S., Manfioletti, G., Croce, C.M., Giancotti, V., and Fusco, A. 2001. Role of the high mobility group A proteins in human lipomas. Carcinogenesis, 22: 1583-1591.
26. Friedmann, M., Holth, L.T., Zoghbi, H.Y., and Reeves, R. 1993. Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res. 21: 4259-4267.
27. Galande, S. 2002. Chromatin (dis)organization and cancer: BUR-binding proteins as biomarkers for cancer. Curr. Cancer Drug Targets, 2: 157-190.
28. Galande, S., and Kohwi-Shigematsu, T. 2000. Linking chromatin architecture to cellular phenotype: BUR-binding proteins in cancer. J. Cell Biochem. Suppl. 35: 36-45.
29. Hess, J.L. 1998. Chromosomal translocations in benign tumors. Am. J. Clin. Path. 109: 251-261.
30. Himes, S.R., Coles, L.S., Reeves, R., and Shannon, M.F. 1996. High Mobility Group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters. Immunity, 5: 479-489.
31. Himes, S.R., Reeves, R., Attema, J., Nissen, M., Li, Y., and Shannon, M.F. 2000. The role of High-Mobility Group I(Y) proteins in expression of IL-2 and T cell proliferation. J. Immunol. 164: 3157-3168.
32. Huth, J.R., Bewley, C.A., Nissen, M.S., Evans, J.N., Reeves, R., Gronenborn, A.M., and Clore, G.M. 1997. The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif. Nat. Struct. Biol. 4: 657-665.
33. Jansen, E., Petit, M.R., Schoenmakers, E.F., Ayoubi, T.A., and van de Ven, W.J. 1999. High mobility group protein HMGI-C: a molecular target in solid tumors. Gene Ther. Mol. Biol. 3: 387-395.
34. John, S., Reeves, R., Lin, J.X., Child, R., Leiden, J.M., Thompson, C.B., and Leonard, W.J. 1995. Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins. Mol. Cell. Biol. 15: 1786-1796.
35. John, S., Robbins, C.M., and Leonard, W.J. 1996. An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. EMBO J. 15: 5627-5635.
36. John, S., Vinkemeier, U., Soldaini, E., Darnell, J.E.J., and Leonard, W.J. 1999. The significance of tetramerization in promoter recruitment by Stat5. Mol. Cell. Biol. 19: 1910-1918.
37. Johns, E.W. 1982. The HMG chromosomal proteins. Academic Press, New York. p. 187.
38. Johnson, K.R., Lehn, D.A., Elton, T.S., Barr, P.J., and Reeves, R. 1988. Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y). J. Biol. Chem. 263: 18 338-18 342.
39. Johnson, K.R., Lehn, D.A., and Reeves, R. 1989. Alternative processing of mRNAs encoding mammalian chromosomal High-Mobility-Group proteins HMG-I and HMG-Y. Mol. Cell Biol. 9: 2114-2123.
40. Kim, H., Kelly, J., and Leonard, W.J. 2001. The basis for IL-2-induced IL-2 receptor alpha chain gene regulation. Importance of two widely separated IL-2 response elements. Immunity, 15: 159-172.
41. Lehn, D.A., Elton, T.S., Johnson, K.R., and Reeves, R. 1988. A conformational study of the sequence specific binding of HMG-I (Y) with the bovine interleukin-2 cDNA. Biochem. Int. 16: 963-971.
42. Leonard, W.J. 1992. The interleukin-2 receptor: structure, function, intercellular messengers and molecular regulation. In Interleukin-2. Edited by J. Waxman and F. Balkwill. Blackwell Scientific Publications Ltd., Oxford, U.K. pp. 29-46.
43. Lomvardas, S., and Thanos, D. 2001. Nucleosome sliding via TBP DNA binding in vivo. Cell, 106: 685-696.
44. Lund, T., Holtlund, J., Fredriksen, M., and Laland, S.G. 1983. On the presence of two new high mobility group-like proteins in HeLa S3 cells. FEBS Lett. 152: 163-167.
45. Maher, J.F., and Nathans, D. 1996. Multivalent DNA-binding properties of the HMG-1 proteins. Proc. Natl. Acad. Sci. U.S.A. 93: 6716-6720.
46. Merika, M., and Thanos, D. 2001. Enhanceosomes. Curr. Opin. Genet. Dev. 11: 205-208.
47. Munshi, N., Merika, M., Yie, J., Senger, K., Chen, G., and Thanos, D. 1998. Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol. Cell, 2: 457-467.
48. Ostvold, A.C., Holtlund, J., and Laland, S.G. 1985. A novel, highly phosphorylated protein of the high-mobility group type present in a variety of proliferating and non-proliferating mammalian cells. Eur. J. Biochem. 153: 469-475.
49. Pedulla, M.L., Treff, N.R., Resar, L.M., and Reeves, R. 2001. Sequence and analysis of the murine Hmgiy (Hmga1) gene locus. Gene, 271: 51-58.
50. Perrella, M.A., Pellacani, A., Wiesel, P., Chin, M.T., Foster, L.C., Ibanez, M., Hsieh, C.M., Reeves, R., Yet, S.F., and Lee, M.E. 1999. High mobility group-I(Y) protein facilitates nuclear factor-kappa B binding and transactivation of the inducible nitricoxide synthase promoter/enhancer. J. Biol. Chem. 274: 9045-9052.
51. Radic, M.Z., Saghbini, M., Elton, T.S., Reeves, R., and Hamkalo, B.A. 1992. Hoechst 33258, distamycin A, and high mobility group protein I (HMG-I) compete for binding to mouse satellite DNA. Chromosoma, 101: 602-608.
52. Reeves, R. 1992. Chromatin changes during the cell cycle. Curr. Opin. Cell Biol. 4: 413-423.
53. Reeves, R. 2000. Structure and function of the HMGI(Y) family of architectural transcription factors. Environ. Health Perspect. 108(Suppl. 5): 803-809.
54. Reeves, R. 2001. Molecular biology of HMGA proteins: hubs of nuclear function. Gene, 277: 63-81.
55. Reeves, R., and Beckerbauer, L. 2001. HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim. Biophys. Acta, 1519: 13-29.
56. Reeves, R., and Nissen, M.S. 1990. The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins: A novel peptide motif for recognizing DNA structure. J. Biol. Chem. 265: 8573-8582.
57. Reeves, R., and Nissen, M.S. 1993. Interaction of high mobility group-I(Y) nonhistone proteins with nucleosome core particles. J. Biol. Chem. 268: 21 137-21 146.
58. Reeves, R., and Nissen, M.S. 1995. Cell cycle regulation and functions of HMG-I(Y). Prog. Cell Cycle Res. 1: 339-349.
59. Reeves, R., and Wolffe, A.P. 1996. Substrate structure influences binding of the non-histone protein HMG-I(Y) to free and nucleosomal DNA. Biochem. 35: 5063-5074.
60. Reeves, R., Elton, T.S., Nissen, M.S., Lehn, D., and Johnson, K.R. 1987. Posttranscriptional gene regulation and specific binding of the nonhistone protein HMG-I by the 3′ untranslated region of bovine interleukin 2 cDNA. Proc. Natl. Acad. Sci. U.S.A. 84: 6531-6535.
61. Reeves, R., Langan, T.A., and Nissen, M.S. 1991. Phosphorylation of the DNA-binding domain of nonhistone high-mobility-group I protein by cdc2 kinase: reduction of binding affinity. Proc. Natl. Acad. Sci. U.S.A. 88: 1671-1675.
62. Reeves, R., Leonard, W.J., and Nissen, M.S. 2000. Binding of HMG-I(Y) imparts architectural specificity to a positioned nucleosome on the promoter of the human interleukin-2 receptor alpha gene. Mol. Cell. Biol. 20: 4666-4679.
63. Rusterholz, C., Henrioud, P.C., and Nabholz, M. 1999. Interleukin 2 (IL-2) regulates the accessibility of the IL-2 response enhancer in the IL-2 receptor α gene to transcription factors. Mol. Cell. Biol. 19: 2681-2689.
64. Solomon, M., Strauss, F., and Varshavsky, A. 1986. A mammalian high mobility group protein recognizes any stretch of six A-T base pairs in duplex DNA. Proc. Natl. Acad. Sci. U.S.A. 83: 1276-1280.
65. Strauss, F., and Varshavsky, A. 1984. A protein binds to a satellite DNA repeat at three specific sites that would be brought into mutual proximity by DNA folding in the nucleosome. Cell, 37: 889-901.
66. Tallini, G., and Dal Cin, P. 1999. HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors. Adv. Anat. Pathol. 6: 237-246.
67. Tamimi, Y., van der Poel, H.G., Karthaus, H.F., Debruyne, F.M., and Schalken, J.A. 1996. A retrospective study of high mobility group protein I(Y) as a progression marker fro prostate cancer determined by in situ hybridization. Br. J. Cancer, 74: 573-578.
68. Thanos, D., and Maniatis, T. 1995. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell, 83: 1091-1100.
69. Varshavsky, A., Levinger, L., Sundin, O., Barsoum, J., Ozkaynak, E., Swerdlow, P., and Finley, D. 1983. Cellular and SV40 chromatin: replication, segregation, ubiquitination, nuclease-hypersensitive sites, HMG-containing nucleosomes, and heterochromatin-specific protein. Cold Spring Harbour Symp. Quant. Biol. 47(Pt. 1): 511-528.
70. Vignali, M., Hassan, A.H., Neely, K.E., and Workman, J.L. 2000. ATP-dependent chromatin-remodeling complexes. Mol. Cell. Biol. 20: 1899-1910.
71. Wang, W., Cot'e, J., Xue, Y., Zhou, S., Khavari, P.A., Biggar, S.R., Muchardt, C., Kalpana, G.V., Goff, S.P., Yaniv, M., Workman, J.L., and Crabtree, G.R. 1996. Purification and biochemical heterogeneity of the mammalian SWI- SNF complex. EMBO J. 15: 5370-5382.
72. Whitley, M.Z., Thanos, D., Read, M.A., Maniatis, T., and Collins, T. 1994. A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol. Cell. Biol. 14: 6464-6475.
73. Wright, P.E., and Dyson, H.J. 1999. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J. Mol. Biol. 293: 321-331.
74. Wu, K., Strauss, F., and Varshavsky, A. 1983. Nucleosome arrangement in green monkey alpha-satellite chromatin. J. Mol. Biol. 170: 93-117.
75. Xiao, H., Sandaltzopoulos, R., Wang, H., Hamiche, A., Ranallo, R., Lee, K., Fu, D., and Wu, C. 2001. Dual functions of largest nurf subunit nurf301 in nucleosome sliding and transcription factor interactions. Mol. Cell, 8: 531-543.
76. Yeh, J.H., Lecine, P., Nunes, J.A., Spicuglia, S., Ferrier, P., Olive, D., and Imbert, J. 2001. Novel CD28-Responsive Enhancer Activated by CREB/ATF and AP-1 Families in the Human Interleukin-2 Receptor alpha-Chain Locus. Mol. Cell Biol. 21: 4515-4527.